OncoSec Medical Inc (ONCSQ)

[trading.jeff]

Repost of $ONCS PR for those who wish to listen/participate in Friday's conference call:

OncoSec to Host 2019 Business Outlook Conference Call on February 1, 2019

-- Company Will Provide a KEYNOTE-695 Update, an Overview of its Registrational-Enabled Cervical Cancer Study and Key 2019 Milestones

SAN DIEGO and PENNINGTON, N.J., Jan. 22, 2019 /PRNewswire/ -- OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing intratumoral cancer immunotherapies, today announced that it will host a 2019 Business Outlook Conference Call and audio webcast on Friday, February 1, 2019 at 9:00 a.m. ET. The Company will provide a clinical update from its KEYNOTE-695 study, an overview of its recently announced collaboration registrational-enabled cervical cancer study with the Gynecologic Oncology Group (GOG) Foundation, as well as a review of key value generating milestones the Company expects to achieve in 2019.

To access the live conference call, please dial [phone] (domestic) or [phone] (international) at least five minutes prior to the start time, and refer to conference ID 4067388. An accompanying presentation will be referenced during the conference call and can be accessed under "Events and Presentations" in the Investors section of OncoSec's website at ir.oncosec.com. A replay will be available shortly after the conference call and can be accessed for 30 days following the call.

https://ir.oncosec.com/press-releases/detail/1978/oncosec-to-host-2019-business-outlook-conference-call-on